These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33544999)

  • 1. COVID-19 Antibody Tests and Their Limitations.
    Liu G; Rusling JF
    ACS Sens; 2021 Mar; 6(3):593-612. PubMed ID: 33544999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study.
    Boum Y; Fai KN; Nikolay B; Mboringong AB; Bebell LM; Ndifon M; Abbah A; Essaka R; Eteki L; Luquero F; Langendorf C; Mbarga NF; Essomba RG; Buri BD; Corine TM; Kameni BT; Mandeng N; Fanne M; Bisseck AZ; Ndongmo CB; Eyangoh S; Hamadou A; Ouamba JP; Koku MT; Njouom R; Claire OM; Esso L; Epée E; Mballa GAE
    Lancet Infect Dis; 2021 Aug; 21(8):1089-1096. PubMed ID: 33773618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies.
    Gutiérrez-Cobos A; Gómez de Frutos S; Domingo García D; Navarro Lara E; Yarci Carrión A; Fontán García-Rodrigo L; Fraile Torres AM; Cardeñoso Domingo L
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):955-961. PubMed ID: 33236268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches.
    Bouman JA; Riou J; Bonhoeffer S; Regoes RR
    PLoS Comput Biol; 2021 Feb; 17(2):e1008728. PubMed ID: 33635863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly Sensitive and Specific Multiplex Antibody Assays To Quantify Immunoglobulins M, A, and G against SARS-CoV-2 Antigens.
    Dobaño C; Vidal M; Santano R; Jiménez A; Chi J; Barrios D; Ruiz-Olalla G; Rodrigo Melero N; Carolis C; Parras D; Serra P; Martínez de Aguirre P; Carmona-Torre F; Reina G; Santamaria P; Mayor A; García-Basteiro AL; Izquierdo L; Aguilar R; Moncunill G
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33127841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2.
    Majdoubi A; Michalski C; O'Connell SE; Dada S; Narpala S; Gelinas J; Mehta D; Cheung C; Winkler DF; Basappa M; Liu AC; Görges M; Barakauskas VE; Irvine M; Mehalko J; Esposito D; Sekirov I; Jassem AN; Goldfarb DM; Pelech S; Douek DC; McDermott AB; Lavoie PM
    JCI Insight; 2021 Apr; 6(8):. PubMed ID: 33720905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease.
    Ogata AF; Maley AM; Wu C; Gilboa T; Norman M; Lazarovits R; Mao CP; Newton G; Chang M; Nguyen K; Kamkaew M; Zhu Q; Gibson TE; Ryan ET; Charles RC; Marasco WA; Walt DR
    Clin Chem; 2020 Dec; 66(12):1562-1572. PubMed ID: 32897389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies.
    James J; Rhodes S; Ross CS; Skinner P; Smith SP; Shipley R; Warren CJ; Goharriz H; McElhinney LM; Temperton N; Wright E; Fooks AR; Clark TW; Brookes SM; Brown IH; Banyard AC
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33924168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
    Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
    J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting.
    Osterman A; Baldauf HM; Eletreby M; Wettengel JM; Afridi SQ; Fuchs T; Holzmann E; Maier A; Döring J; Grzimek-Koschewa N; Muenchhoff M; Protzer U; Kaderali L; Keppler OT
    Med Microbiol Immunol; 2021 Feb; 210(1):65-72. PubMed ID: 33452927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential false-positive reasons for SARS-CoV-2 antibody testing and its solution.
    Ye Q; Zhang T; Lu D
    J Med Virol; 2021 Jul; 93(7):4242-4246. PubMed ID: 33710634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases.
    Kharlamova N; Dunn N; Bedri SK; Jerling S; Almgren M; Faustini F; Gunnarsson I; Rönnelid J; Pullerits R; Gjertsson I; Lundberg K; Månberg A; Pin E; Nilsson P; Hober S; Fink K; Fogdell-Hahn A
    Front Immunol; 2021; 12():666114. PubMed ID: 34012450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.
    Rathe JA; Hemann EA; Eggenberger J; Li Z; Knoll ML; Stokes C; Hsiang TY; Netland J; Takehara KK; Pepper M; Gale M
    J Infect Dis; 2021 Apr; 223(7):1120-1131. PubMed ID: 33367830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the performance of SARS--CoV--2 antibody assays for a longitudinal population-based study of COVID--19 spread in St. Petersburg, Russia.
    Barchuk A; Shirokov D; Sergeeva M; Tursun Zade R; Dudkina O; Tychkova V; Barabanova L; Skougarevskiy D; Danilenko D
    J Med Virol; 2021 Oct; 93(10):5846-5852. PubMed ID: 34081328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating a SARS-CoV-2 screening strategy based on serological tests.
    Baccini M; Mattei A; Rocco E; Vannucci G; Mealli F
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):193-199. PubMed ID: 33412810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
    Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.